Published in J Hosp Infect on September 01, 1983
Institutional outbreaks of rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus transmission. J Hyg (Lond) (1986) 1.57
Chemical disinfection of human rotaviruses: efficacy of commercially-available products in suspension tests. J Hyg (Lond) (1986) 1.41
Interventions for the control of diarrhoeal diseases among young children: chemoprophylaxis. Bull World Health Organ (1985) 1.03
Prevention of surface-to-human transmission of rotaviruses by treatment with disinfectant spray. J Clin Microbiol (1991) 0.91
A report--chronic fatigue syndrome: guidelines for research. J R Soc Med (1991) 7.70
HIV seroprevalence among women attending antenatal clinics in London. Lancet (1992) 4.46
Serum IgM and IgG responses in postnatally acquired rubella. Lancet (1969) 4.16
A serological method for demonstrating recent infection by rubella virus. Br Med J (1967) 4.07
Hepatitis A. BMJ (1991) 3.77
Clinical trial with inactivated hepatitis A vaccine and recommendations for its use. BMJ (1992) 2.76
Liver disease among homosexual males. Lancet (1979) 2.74
Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48
Rapid diagnosis of enterovirus infection by magnetic bead extraction and polymerase chain reaction detection of enterovirus RNA in clinical specimens. J Clin Microbiol (1993) 2.45
Serological assessment of rubella during pregnancy. Br Med J (1970) 2.37
In-vitro detection of human rotaviruses. Lancet (1975) 2.28
Routine use of mu-antibody-capture ELISA for the serological diagnosis of Coxsackie B virus infections. J Med Virol (1986) 2.21
Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis (1983) 2.07
Hepatitis B infections after gynaecological surgery. Lancet (1989) 1.99
Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet (1983) 1.94
Asymptomatic endemic rotavirus infections in the newborn. Lancet (1978) 1.93
Letter: Rotavirus infections in a maternity unit. Lancet (1975) 1.92
The effect of trypsin on the growth of rotavirus. J Gen Virol (1978) 1.86
Rubella viraemia and antibody responses after rubella vaccination and reimmunization. Lancet (1981) 1.86
Hepatitis B vaccine boosting among young healthy adults. Lancet (1994) 1.85
Medical students' risk of infection with bloodborne viruses at home and abroad: questionnaire survey. BMJ (1999) 1.79
Voluntary, named testing for HIV in a community based antenatal clinic: a pilot study. BMJ (1995) 1.78
Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM. Lancet (1975) 1.78
Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma. Lancet (1972) 1.73
Rotavirus infections in a maternity unit. Arch Dis Child (1976) 1.71
Detection of enterovirus RNA in clinical samples by nested polymerase chain reaction for rapid diagnosis of enterovirus infection. J Virol Methods (1994) 1.67
Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) (1982) 1.66
Letter: Rubella-specific IgM and a new inhibitor. Br Med J (1974) 1.66
A case of Lassa fever: experience at St Thomas's Hospital. Br Med J (Clin Res Ed) (1982) 1.59
Clinical evaluation of the turkey-erythrocyte passive-haemagglutination test for hepatitis-B surface antigen. Lancet (1974) 1.59
Hepatitis B vaccine uptake among surgeons at a London teaching hospital: how well are we doing? Ann R Coll Surg Engl (1996) 1.58
Rubella immunity by four different techniques: results of challenge studies. J Med Virol (1980) 1.58
Antibodies to fastidious faecal adenoviruses (species 40 and 41) in sera from children. J Med Virol (1983) 1.57
Studies on rubella virus strain variation by kinetic haemagglutination-inhibition tests. J Gen Virol (1970) 1.56
Coxsackie-B-virus-specific IgM responses in patients with cardiac and other diseases. Lancet (1980) 1.54
Herpes genitalis; clinical and virological studies. Br J Vener Dis (1967) 1.50
PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol (1995) 1.47
Quantitation of HIV: correlation with clinical, virological, and immunological status. J Med Virol (1991) 1.40
Letter: Polio vaccination for travellers. Br Med J (1975) 1.39
Measles must go and with it rubella. Br Med J (Clin Res Ed) (1987) 1.38
Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS (1999) 1.33
Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non-invasive differential sugar permeation. Eur J Clin Invest (1986) 1.33
Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic. Lancet (1990) 1.30
Persistence of rubella antibody 8-18 years after vaccination. Br Med J (Clin Res Ed) (1984) 1.30
Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge. J Infect Dis (1980) 1.30
New Japanese rubella vaccine: comparative trials. Br Med J (1974) 1.26
Maternal rubella at St Thomas' Hospital in 1978 and 1986: support for augmenting the rubella vaccination programme. Lancet (1987) 1.26
Hepatitis A antibodies in London blood donors, medical students, and patients. Lancet (1980) 1.24
Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet (1989) 1.19
Cord blood and breast-milk antibodies in neonatal rotavirus infection. Br Med J (1980) 1.19
Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees. J Infect Dis (1985) 1.18
Willingness of homosexual and bisexual men in London to be screened for human immunodeficiency virus. Br Med J (Clin Res Ed) (1986) 1.16
A comparison of RK-13, vervet monkey kidney and patas monkey kidney cell cultures for the isolation of rubella virus. J Hyg (Lond) (1967) 1.14
Patients with suspected Lassa fever in London during 1984: problems in their management at St Thomas's Hospital. Br Med J (Clin Res Ed) (1985) 1.14
Maternal rubella and the rubella syndrome in infants. Epidemiologic, clinical, and virologic observations. Am J Dis Child (1965) 1.11
Rubella vaccines. Lancet (1979) 1.10
Letter: Diagnosis of rubella. Br Med J (1974) 1.08
Persistence of rubella antibodies after vaccination: detection after experimental challenge. Rev Infect Dis (1985) 1.08
Serological studies in infectious mononucleosis. Br Med J (1969) 1.03
Rubella serology by solid-phase radioimmunoassay: its potential for screening programmes. Clin Exp Immunol (1978) 1.03
Rubella syndrome and thrombocytopenic purpura in newborn infants. Clinical and virologic observations. N Engl J Med (1965) 1.03
Rubella vaccination: remaining problems. Br Med J (Clin Res Ed) (1982) 1.02
Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol (1995) 1.01
Maternal rubella at St. Thomas' Hospital: is there a need to change British vaccination policy? Lancet (1978) 1.00
Interferon response to sendai and rubella viruses in human foetal cultures, leucocytes and placental cultures. J Gen Virol (1971) 1.00
Stability of infectious HIV in clinical samples and isolation from small volumes of whole blood. J Clin Pathol (1994) 0.98
Neonatal rotavirus infection: role of lacteal neutralising alpha1-anti-trypsin and nonimmunoglobulin antiviral activity in protection. J Med Virol (1982) 0.98
Hepatitis B vaccination for medical students. Lancet (1994) 0.98
Is HIV testing in antenatal clinics worthwhile? Can we afford it? AIDS Care (1995) 0.97
BK antibody and virus-specific IgM responses in renal transplant recipients, patients with malignant disease, and healthy people. Br Med J (1977) 0.96
Failure of acyclovir cream in treatment of recurrent herpes labialis. Br Med J (Clin Res Ed) (1985) 0.96
How well do low levels of rubella antibody protect? Lancet (1981) 0.96
False positive rotazyme tests on faecal samples from babies. Lancet (1983) 0.94
Growth of rubella virus in human embryonic organ cultures. J Hyg (Lond) (1968) 0.94
Rubella vaccination: persistence of antibodies for 10-21 years. Lancet (1988) 0.94
Interferon studies with Japanese and U.S. rubella virus strains. Br Med J (1973) 0.94
Automated rubella antibody screening:a cautionary tale. J Med Microbiol (1999) 0.93
Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy. Heart (1996) 0.93
Specific IgM responses after rubella vaccination; potential application following inadvertent vaccination during pregnancy. Br Med J (1977) 0.93
e Antigen among male homosexual patients. Br Med J (1977) 0.93
Systemic lymphoproliferative responses to rotavirus. J Med Virol (1988) 0.93
HIV excretion patterns and specific antibody responses in body fluids. J Med Virol (1990) 0.91
Laboratory investigations in the assessment of rubella during pregnancy. Br Med J (1968) 0.90
Congenital virus infections. BMJ (1990) 0.90
Class-specific antibodies (IgG and IgA) to membrane antigens of Herpes simplex type 2-infected cells in patients with cervical dysplasia and neoplasia. Int J Cancer (1981) 0.89
Identification of hepatitis C virus seroconversion resulting from nosocomial transmission on a haemodialysis unit: implications for infection control and laboratory screening. J Med Virol (1999) 0.89
Prevalence of hepatitis C in tropical communities: the importance of confirmatory assays. J Med Virol (1991) 0.89
High risk genital papillomavirus infections are spread vertically. Rev Med Virol (1999) 0.88
Serological tests for rubella. Lancet (1969) 0.88
Reactivity of enterovirus-specific IgM with infective and defective coxsackie B virions in patients with monotypic and multitypic IgM responses. J Virol Methods (1990) 0.87
Maternal viral load, CD4 cell count and vertical transmission of HIV-1. J Med Virol (1998) 0.87
Rubella virus strains show no major antigenic differences. Intervirology (1992) 0.87
[Electron microscopic studies on rubella infectied human tissue cultures]. Schweiz Med Wochenschr (1967) 0.86
Rubella reinfections. Lancet (1973) 0.86
Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons. J Gen Virol (2000) 0.86
Nucleotide sequence analysis of a major antigenic domain of the E1 glycoprotein of 22 rubella virus isolates. J Gen Virol (1996) 0.86
Rubella reinfection; role of neutralising antibodies and cell-mediated immunity. Clin Diagn Virol (1994) 0.85